1. Generics Bulletin
  2. >>Policy & Regulation

European Industry Urges State Aid Changes To Allow COVID Recovery

Medicines For Europe Calls For Five-Year Temporary Relief To Permit Investment

 
• By Dave Wallace

A five-year period of temporary relief from EU state aid rules should be introduced for countries willing to invest in API and medicine production, Medicines for Europe has urged, insisting that current restrictions do not allow the investment necessary to bolster the supply chain in the wake of COVID-19.

Euro notes alarm clock
Medicines for Europe is calling for a five-year temporary relief from state aid rules to allow sufficient investment in the supply chain • Source: Alamy

Changes to EU state aid rules are necessary so that European countries can invest sufficiently in active pharmaceutical ingredient and medicine production, in order to strengthen the supply chain as the region recovers from the COVID-19 pandemic, off-patent industry association Medicines for Europe has urged.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Generics Bulletin